Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Nouscom Srl

Clinical trials sponsored by Nouscom Srl, explained in plain language.

Not yet finished but already full! 1

New cancer vaccine seeks to train immune system to fight advanced tumors

Disease control Ongoing

This study is testing a new genetic vaccine, called Nous-209, given alongside the immunotherapy drug pembrolizumab (Keytruda®). The goal is to see if this combination is safe and can help control advanced cancers that have a specific genetic feature (MSI-H or dMMR), including col…

Phase: PHASE1, PHASE2 • Sponsor: Nouscom SRL • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC